ClinicalTrials.govpublic full text
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
opioid dependence, on agonist therapy, opioid, dependence, agonist, buprenorphine, naloxone, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 861697
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.